Company: LENZ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100630
Chunk: 86

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 86
---
 for the 90-dayperiod following the closing. Graphite Indemnification Agreements Graphite has entered into agreements, and in the future plan to enter into agreements, to indemnify its directors and executive officers. These agreements, among other things, require Graphite to indemnify these individuals for certain expenses (including attorneys’ fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in Graphite’s right, on account of any services undertaken by such person on behalf of Graphite or that person’s status as a member of the Graphite board of directors to the maximum extent allowed under Delaware law. -45-

Certain Relationships and Related Person Transactions—LENZ OpCo Private Placements of Securities Series B Preferred Stock Financing.In March 2023, LENZ OpCo issued and sold an aggregate of 28,019,181 shares of its Series B Preferred Stock at a purchase price of $2.9801 per share for an aggregate purchase price of approximately $83.5 million. Purchasers of LENZ OpCo’s Series B Preferred Stock included certain of its directors and holders of more than 5% of its capital stock at the time of the financing. The following table presents the number of shares and the total purchase price paid by these entities:

| Investor                                           |     | Shares of Series 
 B Preferred      
 Stock            |            |     | Total Purchase 
 Price          |            |
|:---------------------------------------------------|:----|:-----------------|-----------:|:----|:---------------|-----------:|
| Alpha Wave Ventures II, LP(1)                      |     |                  | 13,422,368 |     | $              | 39,999,999 |
| Point72 Biotech Private Investments, LLC-Series LT |     |                  |  5,033,388 |     | $              | 15,000,000 |
| Entities affiliated with RA Capital(2)             |     |                  |  5,033,388 |     | $              | 15,000,000 |
| Entities affiliated with Versant Ventures(3)       |     |                  |    167,779 |     | $              |    499,998 |
| McCollum Living Trust(4)                           |     |                  |    167,779 |     | $              |    499,998 |
| Entities affiliated with RTW                       |     |                  |    167,779 |     | $              |